Ebola Research
-
{
- All
- News
-
WHO Fast-Tracks Vaccines, Drugs Against Deadly Ebola Bundibugyo Strain
The Bundibugyo strain is one of several types of Ebola viruses known to infect humans. While Ebola is linked to severe bleeding, organ failure, and high death rates, different strains can behave differently.
-
WHO Urges Ebola Treatments, Vaccines Be Tested Only In Trials Amid Bundibugyo Outbreak
The World Health Organization said that experimental treatments and vaccines for Ebola caused by the Bundibugyo virus should only be used in clinical trials, as it works with affected countries to assess their safety and effectiveness.
-
Centre On Ebola Alert: Health Minister Reviews Preparedness Amid WHO Emergency
The Centre has stepped up Ebola preparedness measures across the country after the World Health Organization declared the ongoing outbreak a Public Health Emergency of International Concern (PHEIC), with Union Health Minister JP Nadda reviewing surveillance and response mechanisms amid global concerns over the spread of the virus. Officials said...
-
Oxford Scientists Are Developing First-Ever Vaccine For Rare Bundibugyo Ebola Strain
Researchers at Oxford University are developing the novel jab targeting the rare strain. The World Health Organization says
-
No Ebola Case In India, Airports Put On Alert After WHO Warning
The Centre has reviewed standard operating procedures for screening, surveillance, quarantine and case management, while laboratory preparedness is also being ramped up. The National Institute of Virology (NIV), Pune has been designated for Ebola tes
-
Chinese Scientists Identify Key Mutation In Ebola Virus, May Improve Outbreak Surveillance
Chinese researchers have unveiled a crucial mutation in the Ebola virus that significantly enhanced its infectivity during a major outbreak, providing new insights for epidemic surveillance and drug development.
-
"Spillover Events" From 4 Killer Viruses Like Ebola Will Kill 12 Times More People Than 2050: Study
The research is based on analysis of 60 years of historical epidemiological data.
-
Ebola Survivors Can Trigger Outbreaks Years After Infection, New Research Shows
Ebola survivors can relapse and trigger outbreaks at least five years after infection, and long-term follow-up of former patients is needed to prevent devastating flare-ups, according to new research.
-
New Testing Of Ebola Vaccine To Start Next Month In Canada
An Ebola vaccine developed by Canadian researchers and considered by the WHO to be the first effective treatment against the virus will soon start a new phase of clinical trials, Ottawa announced Tuesday.
-
Ebola Virus Lasts In Semen For Up To 565 Days: Study
The largest analysis yet has found Ebola virus particles present in semen as long as 565 days after recovery from an infection, highlighting the potential role of sex in sparking another outbreak, researchers reported on Tuesday.
-
New Form Of Ebola Virus May Cause Disease In Humans
The Reston virus, a member of the Ebola virus family which is known to circulate in domestic pigs in Asia, may acquire the few mutations necessary to cause disease in humans and to develop into a novel health threat, researchers have warned.
-
'Low' Risk Of Getting Ebola From Survivor: Study
The risk of catching Ebola from a survivor is generally low since the virus disappears from the blood within weeks, but it may persist in semen for many months, researchers said Monday.
-
Ebola: Low-Cost Portable Device Discovered For Detecting Infection
Researchers have developed a low-cost and portable diagnostic device that can be used to detect Ebola infection and many other diseases.
-
White House, House Republicans Spar Over Zika, Ebola Funding
The White House said on Friday that it would be "profoundly unwise" to plow money set aside for Ebola-related projects into research and mitigation efforts for the mosquito-borne Zika virus as several top Republican lawmakers have requested.
-
Brazil Researchers Hope To Test Zika Virus Treatment In A Year
Leading researchers in Brazil are borrowing techniques used to accelerate the fight against Ebola in the hope of developing a Zika virus treatment that could be tested in humans in a year.
-
WHO Fast-Tracks Vaccines, Drugs Against Deadly Ebola Bundibugyo Strain
The Bundibugyo strain is one of several types of Ebola viruses known to infect humans. While Ebola is linked to severe bleeding, organ failure, and high death rates, different strains can behave differently.
-
WHO Urges Ebola Treatments, Vaccines Be Tested Only In Trials Amid Bundibugyo Outbreak
The World Health Organization said that experimental treatments and vaccines for Ebola caused by the Bundibugyo virus should only be used in clinical trials, as it works with affected countries to assess their safety and effectiveness.
-
Centre On Ebola Alert: Health Minister Reviews Preparedness Amid WHO Emergency
The Centre has stepped up Ebola preparedness measures across the country after the World Health Organization declared the ongoing outbreak a Public Health Emergency of International Concern (PHEIC), with Union Health Minister JP Nadda reviewing surveillance and response mechanisms amid global concerns over the spread of the virus. Officials said...
-
Oxford Scientists Are Developing First-Ever Vaccine For Rare Bundibugyo Ebola Strain
Researchers at Oxford University are developing the novel jab targeting the rare strain. The World Health Organization says
-
No Ebola Case In India, Airports Put On Alert After WHO Warning
The Centre has reviewed standard operating procedures for screening, surveillance, quarantine and case management, while laboratory preparedness is also being ramped up. The National Institute of Virology (NIV), Pune has been designated for Ebola tes
-
Chinese Scientists Identify Key Mutation In Ebola Virus, May Improve Outbreak Surveillance
Chinese researchers have unveiled a crucial mutation in the Ebola virus that significantly enhanced its infectivity during a major outbreak, providing new insights for epidemic surveillance and drug development.
-
"Spillover Events" From 4 Killer Viruses Like Ebola Will Kill 12 Times More People Than 2050: Study
The research is based on analysis of 60 years of historical epidemiological data.
-
Ebola Survivors Can Trigger Outbreaks Years After Infection, New Research Shows
Ebola survivors can relapse and trigger outbreaks at least five years after infection, and long-term follow-up of former patients is needed to prevent devastating flare-ups, according to new research.
-
New Testing Of Ebola Vaccine To Start Next Month In Canada
An Ebola vaccine developed by Canadian researchers and considered by the WHO to be the first effective treatment against the virus will soon start a new phase of clinical trials, Ottawa announced Tuesday.
-
Ebola Virus Lasts In Semen For Up To 565 Days: Study
The largest analysis yet has found Ebola virus particles present in semen as long as 565 days after recovery from an infection, highlighting the potential role of sex in sparking another outbreak, researchers reported on Tuesday.
-
New Form Of Ebola Virus May Cause Disease In Humans
The Reston virus, a member of the Ebola virus family which is known to circulate in domestic pigs in Asia, may acquire the few mutations necessary to cause disease in humans and to develop into a novel health threat, researchers have warned.
-
'Low' Risk Of Getting Ebola From Survivor: Study
The risk of catching Ebola from a survivor is generally low since the virus disappears from the blood within weeks, but it may persist in semen for many months, researchers said Monday.
-
Ebola: Low-Cost Portable Device Discovered For Detecting Infection
Researchers have developed a low-cost and portable diagnostic device that can be used to detect Ebola infection and many other diseases.
-
White House, House Republicans Spar Over Zika, Ebola Funding
The White House said on Friday that it would be "profoundly unwise" to plow money set aside for Ebola-related projects into research and mitigation efforts for the mosquito-borne Zika virus as several top Republican lawmakers have requested.
-
Brazil Researchers Hope To Test Zika Virus Treatment In A Year
Leading researchers in Brazil are borrowing techniques used to accelerate the fight against Ebola in the hope of developing a Zika virus treatment that could be tested in humans in a year.
